ES2162941T3 - Compuestos antimicrobianos de feniloxazolidinona. - Google Patents

Compuestos antimicrobianos de feniloxazolidinona.

Info

Publication number
ES2162941T3
ES2162941T3 ES95933718T ES95933718T ES2162941T3 ES 2162941 T3 ES2162941 T3 ES 2162941T3 ES 95933718 T ES95933718 T ES 95933718T ES 95933718 T ES95933718 T ES 95933718T ES 2162941 T3 ES2162941 T3 ES 2162941T3
Authority
ES
Spain
Prior art keywords
phenyloxazolidinone
antimicrobial compounds
species
compounds
bacteroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933718T
Other languages
English (en)
Inventor
Douglas K Hutchinson
Michael R Barbachyn
Mikio Taniguchi
Kiyotaka Munesada
Hiroyoshi Yamada
Steven J Brickner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2162941T3 publication Critical patent/ES2162941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRESENTA UN COMPUESTO DE FORMULA ESTRUCTURAL (I), O SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO, DONDE: Q SE SELECCIONA A PARTIR DE LAS ESTRUCTURAS I, II, III, IV Y V. DICHOS COMPUESTOS SON UTILES COMO AGENTES ANTIMICROBIANOS, EFECTIVOS FRENTE A DIVERSOS PATOGENOS ANIMALES Y HUMANOS, ESPECIALMENTE BACTERIAS GRAM-POSITIVAS, INCLUYENDO ESTAFILOCOCOS , ENTEROCOCOS Y ESTREPTOCOCOS MULTI-RESISTENTES, ASI COMO ORGANISMOS ANAEROBIOS, COMO ESPECIES DE BACTEROIDES Y CLOSTRIDIA, Y BACTERIAS ACIDORESISTENTES, COMO MYCOBACTERIUM TUBERCULOSIS Y OTRAS ESPECIES MICOBACTERIANAS.
ES95933718T 1994-10-26 1995-09-12 Compuestos antimicrobianos de feniloxazolidinona. Expired - Lifetime ES2162941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32971794A 1994-10-26 1994-10-26

Publications (1)

Publication Number Publication Date
ES2162941T3 true ES2162941T3 (es) 2002-01-16

Family

ID=23286694

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933718T Expired - Lifetime ES2162941T3 (es) 1994-10-26 1995-09-12 Compuestos antimicrobianos de feniloxazolidinona.

Country Status (22)

Country Link
EP (1) EP0788498B1 (es)
JP (1) JP3933198B2 (es)
KR (1) KR100383403B1 (es)
CN (1) CN1068325C (es)
AT (1) ATE204277T1 (es)
AU (1) AU694271B2 (es)
BR (1) BR9509136A (es)
CA (1) CA2200433C (es)
CZ (1) CZ291847B6 (es)
DE (1) DE69522234T2 (es)
DK (1) DK0788498T3 (es)
ES (1) ES2162941T3 (es)
FI (1) FI971774A (es)
HU (1) HU224044B1 (es)
NO (1) NO309478B1 (es)
NZ (1) NZ293741A (es)
PL (1) PL183512B1 (es)
PT (1) PT788498E (es)
RU (1) RU2134692C1 (es)
SI (1) SI0788498T1 (es)
SK (1) SK282869B6 (es)
WO (1) WO1996013502A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11512429A (ja) * 1995-09-15 1999-10-26 ファルマシア・アンド・アップジョン・カンパニー アミノアリールオキサゾリジノン ｎ−オキシド
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
CZ298060B6 (cs) * 1996-04-11 2007-06-06 Pharmacia & Upjohn Company Zpusob prípravy oxazolidinonu
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
EP1049682A1 (en) 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
ATE222894T1 (de) * 1998-02-13 2002-09-15 Upjohn Co Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
TR200003595T2 (tr) 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
DE19919708A1 (de) * 1999-04-30 2001-03-01 Univ Stuttgart Stufenweise Alkylierung von polymeren Aminen
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
FR2802091A1 (fr) * 1999-12-08 2001-06-15 Oreal Compositions pour la teinture des fibres keratiniques contenant des derives de paraphenylenediamine a groupement azetidinyle
WO2002032857A1 (en) 2000-10-17 2002-04-25 Pharmacia & Upjohn Company Methods of producing oxazolidinone compounds
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US6951863B2 (en) 2001-02-07 2005-10-04 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
CA2492743A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
EP1539745B1 (en) 2002-08-12 2006-03-29 Pharmacia & Upjohn Company LLC N-aryl-2-oxazolidinones and their derivatives
BR0316483A (pt) 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
FR2862969A1 (fr) 2003-11-28 2005-06-03 Oreal Procede de preparation de derives paraphenylenediamine a groupement pyrrolidinyle, substitue par un radical azote, et composes intermediaires
CA2614105A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
WO2007004049A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinones containing azetidine as antibacterial agents
EP2175721B1 (en) 2007-07-24 2017-02-08 Dow Global Technologies LLC Methods of and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids and systems used with them
EP2173176B1 (en) 2007-07-24 2017-09-06 Dow Global Technologies LLC Methods of and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids
EP2141161A1 (en) * 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
EP2141162A1 (en) * 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
CN101798302B (zh) * 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
US20130296569A1 (en) 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506659A1 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE68929303T2 (de) * 1988-09-15 2002-05-02 Pharmacia & Upjohn Co., Kalamazoo 3-(Stickstoff substituierte)phenyl-5-beta-amidomethyloxazoliden-2-one
CA2119556C (en) * 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones

Also Published As

Publication number Publication date
KR970707123A (ko) 1997-12-01
EP0788498A1 (en) 1997-08-13
SK49497A3 (en) 1998-01-14
BR9509136A (pt) 1998-07-21
RU2134692C1 (ru) 1999-08-20
KR100383403B1 (ko) 2004-05-31
HU224044B1 (hu) 2005-05-30
SI0788498T1 (en) 2001-12-31
JPH10508017A (ja) 1998-08-04
CA2200433A1 (en) 1996-05-09
PT788498E (pt) 2002-02-28
AU3625495A (en) 1996-05-23
CA2200433C (en) 2006-02-07
DE69522234D1 (de) 2001-09-20
CN1068325C (zh) 2001-07-11
DK0788498T3 (da) 2001-11-05
ATE204277T1 (de) 2001-09-15
EP0788498B1 (en) 2001-08-16
DE69522234T2 (de) 2002-05-16
SK282869B6 (sk) 2003-01-09
NZ293741A (en) 1998-06-26
NO971946D0 (no) 1997-04-25
NO971946L (no) 1997-06-25
FI971774A0 (fi) 1997-04-25
CN1162312A (zh) 1997-10-15
AU694271B2 (en) 1998-07-16
HUT77602A (hu) 1998-06-29
NO309478B1 (no) 2001-02-05
FI971774A (fi) 1997-04-25
PL183512B1 (pl) 2002-06-28
PL319873A1 (en) 1997-09-01
JP3933198B2 (ja) 2007-06-20
WO1996013502A1 (en) 1996-05-09
CZ291847B6 (cs) 2003-06-18
CZ121797A3 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
ES2162941T3 (es) Compuestos antimicrobianos de feniloxazolidinona.
DK0792273T3 (da) Bicycliske oxazin- og thiazin-oxazolidinon-antibakterielle midler
ZA968661B (en) Oxazolidinone antibacterial agent with tricyclic substituents.
CA2168560A1 (en) Substituted oxazine and thiazine oxazolidinone antimicrobials
AU6964096A (en) Aminoaryl oxazolidinone n-oxides
MX9703040A (es) Antimicrobianos de feniloxazolidinona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 788498

Country of ref document: ES